Medicine | Oncology
Prostate cancer
Prognosis
Predictions on outcomes after primary treatment


Home > Disciplines > Medicine > Oncology > Prostate cancer > Prognosis > Predictions on outcomes after primary treatment


OUTCOMES AFTER MONITORING, SURGERY OR RADIOTHERAPY


.

Abdel-Rahman O.
Outcomes of Prostatectomy versus Radiation Therapy in the Management of Clinically Localized Prostate Cancer Patients Within the PLCO Trial.
Clin Genitourin Cancer. 2019 Jan 4. pii: S1558-7673(19)30004-7. doi: 10.1016/j.clgc.2018.12.010. [Epub ahead of print]
Source | Full text | Similar articles



.

Albertsen PC.
Re: 10-Year Outcomes After Monitoring, Surgery or Radiotherapy for Localized Prostate Cancer.
Eur Urol. 2017 Jun 8. pii: S0302-2838(17)30485-2. doi: 10.1016/j.eururo.2017.05.045. [Epub ahead of print]
Source | Full text | Similar articles
Referring to: Hamdy FC et al, 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer.
N Engl J Med. 2016 Oct 13;375(15):1415-1424. Epub 2016 Sep 14.
Source , Full text



.

D'Amico AV.
Active Surveillance Versus Treatment of Prostate Cancer: Should Metastasis Be the Primary End Point?
J Clin Oncol. 2017 Feb 27:JCO2016709527. doi: 10.1200/JCO.2016.70.9527. [Epub ahead of print]
Source | Full text | Similar articles



.

Donovan JL, Hamdy FC, Lane JA, Mason M, Metcalfe C, Walsh E, Blazeby JM, Peters TJ, Holding P, Bonnington S, Lennon T, Bradshaw L, Cooper D, Herbert P, Howson J, Jones A, Lyons N, Salter E, Thompson P, Tidball S, Blaikie J, Gray C, Bollina P, Catto J, Doble A, Doherty A, Gillatt D, Kockelbergh R, Kynaston H, Paul A, Powell P, Prescott S, Rosario DJ, Rowe E, Davis M, Turner EL, Martin RM, Neal DE; ProtecT Study Group.
Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer.
N Engl J Med. 2016 Oct 13;375(15):1425-1437. Epub 2016 Sep 14.
Source | Full text | Similar articles



.

Hamdy FC, Donovan JL, Lane JA, Mason M, Metcalfe C, Holding P, Davis M, Peters TJ, Turner EL, Martin RM, Oxley J, Robinson M, Staffurth J, Walsh E, Bollina P, Catto J, Doble A, Doherty A, Gillatt D, Kockelbergh R, Kynaston H, Paul A, Powell P, Prescott S, Rosario DJ, Rowe E, Neal DE; ProtecT Study Group.
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer.
N Engl J Med. 2016 Oct 13;375(15):1415-1424. Epub 2016 Sep 14.
Source | Full text | Similar articles



.

Whalen MJ, Pak JS, Lascano D, Ahlborn D, Matulay JT, McKiernan JM, Benson MC, Wenske S.
Oncologic Outcomes of Definitive Treatments for Low- and Intermediate-Risk Prostate Cancer After a Period of Active Surveillance.
Clin Genitourin Cancer. 2017 Oct 16. pii: S1558-7673(17)30313-0. doi: 10.1016/j.clgc.2017.10.007. [Epub ahead of print]
Source | Full text | Similar articles



FREQUENCY OF PSA TESTS


.

Nabhan M, Kim SP, Shah ND, Bagniewski SM, Shi Q, Karnes RJ, Weight CJ, Davis BJ, Kohli M, Tilburt JC.
The relationship of the intensity of posttreatment prostate-specific antigen surveillance and prostate cancer outcomes: results from a population-based cohort.
Mayo Clin Proc. 2012 Jun;87(6):540-7. doi: 10.1016/j.mayocp.2012.01.017.
Source | Full text | Similar articles



BIOCHEMICAL RECURRENCE




PROGNOSTIC VALUE OF BCR


.**

Van den Broeck T, van den Bergh RCN, Arfi N, Gross T, Moris L, Briers E, Cumberbatch M, De Santis M, Tilki D, Fanti S, Fossati N, Gillessen S, Grummet JP, Henry AM, Lardas M, Liew M, Rouvière O, Pecanka J, Mason MD, Schoots IG, van Der Kwast TH, van Der Poel HG, Wiegel T, Willemse PM, Yuan Y, Lam TB, Cornford P, Mottet N.
Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review.
Eur Urol. 2018 Oct 17. pii: S0302-2838(18)30752-8. doi: 10.1016/j.eururo.2018.10.011. [Epub ahead of print]
Source | Full text | Similar articles



.

Van den Broeck T, Mottet N, Lam T.
Reply to Xueliang Zhou and Xinwei Han's Letter to the Editor re: Thomas Van den Broeck, Roderick C.N. van den Bergh, Nicolas Arfi, et al. Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2018.10.011.
Eur Urol. 2019 Apr 6. pii: S0302-2838(19)30255-6. doi: 10.1016/j.eururo.2019.03.027. [Epub ahead of print]
Source | Full text | Similar articles



.

Zhou X, Han X.
Re: Thomas Van den Broeck, Roderick C.N. van den Bergh, Nicolas Arfi, et al. Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2018.10.011.
Eur Urol. 2019 Apr 1. pii: S0302-2838(19)30256-8. doi: 10.1016/j.eururo.2019.03.028. [Epub ahead of print]
Source | Full text | Similar articles



ANATOMIC SITE


.

Teloken PE, Li J, Woods CG, Cohen RJ.
The impact of prostate cancer zonal origin on pathological parameters at radical prostatectomy and subsequent biochemical failure.
J Urol. 2017 May 26. pii: S0022-5347(17)74541-7. doi: 10.1016/j.juro.2017.05.075. [Epub ahead of print]
Source | Full text | Similar articles